Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Pediatric Acute Kidney Injury in COVID-19

ClinicalTrials.gov ID: NCT04466306

Public ClinicalTrials.gov record NCT04466306. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 9:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

SARS-CoV2 Pediatric Acute Kidney Injury Registry and Collaborative

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is an observational registry of children with or suspected to have SARS CoV2 (COVID-19) admitted to pediatric intensive care units (PICU). This registry will help describe the prevalence, rate and severity of acute kidney injury (AKI) in children with Severe Acute Respiratory Syndrome Coronavirus-2(SARS CoV2) across the world. The registry will be developed using a point prevalence methodology and then full retrospective review. Once a week, from April through June 2020, data collection will occur in "real-time" to estimate a weekly point prevalence of AKI and renal replacement therapy (RRT). The operational definition of "patients under investigation" (PUIs) will be used to identify the denominator of patients to be studied. The PUIs will be cohorted into SARS CoV2 test positive, test negative, test pending, or test unavailable. The primary aim of this study is to deliver a global, objective data driven analysis of the burden of AKI in virus positive patients or patients under investigation (PUI) who are admitted to the pediatric intensive care unit.

Study identification

NCT ID
NCT04466306
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Enrollment
400 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
7 Days to 25 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 15, 2020 (Actual)
Primary completion
Jul 1, 2021 (Actual)
Completion
Jul 1, 2021 (Actual)
Last update posted
Dec 3, 2021

2020 – 2021

United States locations

U.S. sites
33
U.S. states
22
U.S. cities
32
Facility City State ZIP Site status
Children's Hospital of Alabama Birmingham Alabama 35233 —
Arkansas Children's Research Institute Little Rock Arkansas 72202 —
Cedars-Sinai Maxine Dunitz Children's Health Center Los Angeles California 90048 —
UCLA Mattel Children's Hospital Los Angeles California 90095 —
Lucile Packard Children's Hospital Standford Palo Alto California 94304 —
Rady Children's Hospital San Diego San Diego California 92123 —
Children's Hospital Colorado Aurora Colorado 80045 —
Yale New Haven Children's Hospital New Haven Connecticut 06504 —
UF Health Shands Children's Hospital Gainesville Florida 32608 —
Children's Healthcare of Atlanta Atlanta Georgia 30322 —
Comer Children's Hospital - UChicago Medicine Chicago Illinois 60637 —
Riley Hospital for Children Indianapolis Indiana 46202 —
University of Iowa Stead Family Children's Hospital Iowa City Iowa 52242 —
Children's Mercy Kansas City Kansas 64108 —
John Hopkins Children's Center Baltimore Maryland 21287 —
Boston Children's Hospital Boston Massachusetts 02115 —
C.S. Mott Children's Hospital Ann Arbor Michigan 48109 —
Helen DeVos Children's Hospital Grand Rapids Michigan 49503 —
Beaumont Children's Hospital Royal Oak Michigan 48073 —
St. Louis Children's Hospital of Washington University St Louis Missouri 63110 —
Oishei Children's Hospital of Buffalo Buffalo New York 14203 —
Golisano Children's Hospital - University of Rochester Medicine Rochester New York 14642 —
Stony Brook Children's Hospital Stony Brook New York 11794 —
Levine Children's Hospital Charlotte North Carolina 28203 —
Duke Children's Hospital and Health Center Durham North Carolina 27705 —
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229 —
Nationwide Children's Hospital Columbus Ohio 43205 —
Penn State Children's Hospital Hershey Pennsylvania 17033 —
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 —
UPMC Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15224 —
Lifespan Hasbro Children's Hospital Providence Rhode Island 02903 —
Medical University of South Carolina Shawn Jenkins Children's Hospital Charleston South Carolina 29425 —
Seattle Children's Hospital Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04466306, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 3, 2021 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04466306 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →